BUSINESS● LOWSep 29 · Sep 29, 2026, 9:45 AM
AstraZeneca invests £1 . 5bn into US firm Summit for cancer drug tie - up
impartialreporter.com · United Kingdom · global
AstraZeneca is investing £1.5 billion into US firm Summit to collaborate on a cancer drug. This partnership aims to advance cancer treatment development between the two companies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited Kingdom and nearby eventsMore from United KingdomLatest stories and threat level
More from United Kingdom
POLITICS6h agoAl Jazeera investigation that reveals Zimbabwean government paid united kingdom terrorist groups to force lifting of sanctionsnewzimbabwe.com · ZimbabweWORLD14h agoSecond thylacine head hits united kingdom auction house just weeks after first rare saleabc.net.au · AustraliaBUSINESS22h agoRoundup : united kingdom inflation hits highest level since November 2025 , adding pressure ahead of Budgetbignewsnetwork.com · United StatesPOLITICS1d agoArab News | united kingdom approves long - delayed Jackdaw gas field on energy security groundsarabnews.com · Saudi Arabia
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS13m agoModerna shares plunge after leak of partial cancer vaccine dataCNBCBUSINESS14m agoLockheed Martin forecasts $80B-$82B 2026 sales while scaling $8B munitions investment through 2030Seeking Alpha Tech